Lung AI vs Sleepiz One+

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Exo
VS
by Sleepiz

AI Verdict

Tool A, Exo Lung AI, is a handheld ultrasound device with AI for real-time cardiac and lung imaging and diagnosis, focusing on conditions like pleural effusion and consolidation. Tool B, Sleepiz One+, is a contactless remote patient monitoring device that collects biometric data, primarily heart rate and respiration rate, for chronic conditions and sleep apnea screening. While both tools utilize AI and address aspects of pulmonology and cardiology, their core functionalities and deployment methods—point-of-care imaging versus passive remote monitoring—make them adjacent rather than direct competitors.

Choose Lung AI if…

Choose Lung AI if you need real-time, on-demand diagnostic imaging at the point of care, particularly in emergency medicine or critical care settings. Its handheld, AI-powered ultrasound capabilities are ideal for quickly assessing conditions like pleural effusion or consolidation/atelectasis, and for guiding interventions without internet connectivity.

View Lung AI →

Choose Sleepiz One+ if…

Choose Sleepiz One+ if you require continuous, contactless remote patient monitoring for chronic conditions, especially in senior care or for sleep apnea screening. Its ability to passively collect respiration and heart rate data from a patient's bedside over extended periods is well-suited for long-term health trend analysis and remote management.

View Sleepiz One+ →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Lung AI Sleepiz One+
Pricing Contact for pricing Contact for pricing
Deployment On-device (integrated with Exo Iris handheld ultrasound device) Wall-mounted or bedside table placement, Wi-Fi connectivity
BAA Available Yes AI-estimated Unknown
FDA Status 1 AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Sleepiz One+

Sleepiz One+ is designed for easy setup and contactless monitoring, making it highly user-friendly for patients at home, including older adults. Its 'set it and forget it' approach and minimal setup time (under 3 minutes) contribute to high patient compliance. In contrast, Lung AI, while offering guided image capture, requires active operation of a handheld ultrasound device, which may present a steeper learning curve for some users, despite its aim to simplify the process for both early POCUS users and seasoned experts.

Clinical Value

Lung AI

Lung AI offers real-time, AI-powered detection of critical cardiac and lung conditions like pleural effusion, consolidation/atelectasis, and automated indicators for heart failure, directly at the point of care. Clinical studies have shown that AI assistance with Lung AI significantly improves the accuracy of lung ultrasound interpretation, particularly for less experienced users, and provides high sensitivity and specificity for detecting these conditions. Sleepiz One+ provides valuable contactless monitoring of respiration and heart rate, and sleep apnea screening, which is crucial for remote patient monitoring and chronic condition management. However, Lung AI's immediate diagnostic capabilities for acute conditions at the point of care present a more direct and potentially higher clinical impact in emergency and critical care settings.

Pricing & Value

Tie

Both tools require contacting the company for specific pricing, indicating a lack of public transparency. Sleepiz One+ highlights that physicians can reimburse its use through CPT codes for remote patient monitoring, offering a clear path to financial value for healthcare providers. While Lung AI's pricing isn't detailed, its integration with a handheld ultrasound device suggests a potentially higher initial investment, though it aims to reduce diagnostic error and accelerate patient care pathways, which could lead to long-term cost savings. Without concrete pricing for either, it's difficult to definitively declare a winner in terms of overall value.

Enterprise Readiness

Lung AI

Exo's Lung AI is integrated with the Exo Iris handheld ultrasound device, offering an on-device AI processing that operates without internet, which is crucial for diverse clinical settings, including those with limited connectivity. Exo also emphasizes its rigorous AI validation process in compliance with FDA regulations, using a large dataset from various patient populations and diagnostic types, demonstrating a robust approach to enterprise deployment. Sleepiz One+ is designed for easy setup and deployment in both clinical and home environments with Wi-Fi connectivity and cellular data transmission, and is HIPAA compliant with BAA in place. However, the on-device, offline capability of Lung AI and its broader application across emergency and critical care settings suggest a higher degree of enterprise readiness for immediate, critical decision-making in varied environments.

Innovation

Lung AI

Lung AI, as part of the Exo Iris handheld ultrasound platform, represents significant innovation by integrating AI directly into a portable imaging device for real-time cardiac and lung diagnostics. Features like SweepAI for continuous image quality monitoring and guided image capture are innovative in simplifying complex ultrasound procedures for a wider range of users. Sleepiz One+ is also innovative with its contactless radar technology for remote patient monitoring and sleep apnea screening. However, the real-time, on-device AI processing for diagnostic imaging in a handheld form factor, addressing a broader range of acute conditions, gives Lung AI an edge in innovation within the healthcare AI space.

Support & Docs

Tie

Both companies provide essential documentation and support. Sleepiz offers quick start guides and instruction manuals for its device, and its website includes FAQs and contact information for support. Exo, through its broader platform, offers POCUS education and training, and collaborative research opportunities, suggesting comprehensive support for its users. Without more specific details on the breadth and accessibility of their support channels (e.g., 24/7 support, dedicated account managers), it is difficult to definitively pick a winner, resulting in a tie.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Lung AI Sleepiz One+
Name Lung AI Sleepiz One+
Company Exo Sleepiz
Tagline Handheld AI Ultrasound for Smarter Cardiac and Lung Scanning. Contactless Monitoring for Senior Care
Categories Cardiology AI, Radiology & Imaging AI Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties Cardiology, Emergency Medicine, Pulmonology Geriatrics, Pulmonology, Sleep Medicine
Key Features (Examples) AI-powered detection of pleural effusion, AI-powered detection of consolidation/atelectasis, Real-time feedback and image quality monitoring (SweepAI) Contactless monitoring (radar technology), Measures respiration rate, Measures heart rate

Videos

Demos, reviews, and walkthroughs featuring Lung AI and Sleepiz One+.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Lung AI is designed to integrate into existing imaging workflows, working with current CADe and PACS environments without requiring new workstations or workflow changes, making it suitable for radiologists and pulmonologists. Sleepiz One+ is a contactless remote patient monitoring device that can be placed at a patient's bedside, and its data is accessible via a web application, fitting into remote patient monitoring workflows for geriatrics, pulmonology, and sleep medicine.
Lung AI demonstrates high accuracy in detecting pleural effusion with a sensitivity of 0.967 and specificity of 0.912, and for consolidation/atelectasis with a sensitivity of 0.968 and specificity of 0.945. Sleepiz One+ has an accuracy rate of 99% for breathing rate and 96% for heart rate measurements when compared to gold-standard methods.
Lung AI aims to simplify lung ultrasound interpretation, particularly benefiting less experienced users by improving their accuracy in detecting pleural effusion and consolidation/atelectasis. Sleepiz One+ is designed for ease of installation and use, offering continuous and accurate health status checks without patient interaction once set up.
While specific audit trail features for Lung AI are not detailed, generally, AI systems in healthcare require comprehensive, immutable records of decisions, inputs, outputs, model versions, and human review sign-offs to ensure compliance and accountability. Sleepiz One+ provides data access and analysis through a web application, and for remote patient monitoring, audit trails typically involve logging usage periods, parameters, datasets, and reviewer actions.
Lung AI's on-device AI processing means it operates without an internet connection, which could facilitate deployment in various settings, including those with limited connectivity. Sleepiz One+ is a contactless device that can be easily set up in a patient's home, and its data is accessible via a web application, supporting scalable remote patient monitoring across multiple locations.
Physicians should consider Lung AI for real-time, AI-powered assistance in cardiac and lung ultrasound imaging, particularly for diagnosing conditions like pleural effusion, consolidation, and cardiac issues at the point of care. Sleepiz One+ is more suited for continuous, contactless remote monitoring of respiration and heart rate, especially for chronic conditions and sleep apnea screening in geriatric or pulmonology patients, providing insights into disease progression or remission.

Backers

Who funded each tool's parent company.

Sleepiz One+

AI Tool Finder
AI-powered search. Results may not be comprehensive.